Dr. Royal is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
12481 High Bluff Dr
Ste 200
San Diego, CA 92130Phone+1 858-436-1427Fax+1 858-436-1401
Education & Training
- Allegheny Health Network Medical Education Consortium (AGH/WPH)Residency, Anesthesiology, 1990 - 1992
- National Capital ConsortiumResidency, Internal Medicine, 1981 - 1984
- University of Massachusetts Medical SchoolClass of 1981
Certifications & Licensure
- FL State Medical License 2024 - 2027
- CA State Medical License 2003 - 2026
- NC State Medical License 2017 - 2020
- PA State Medical License 1988 - 2006
- OK State Medical License 1994 - 2003
- MD State Medical License 1984 - 1991
- American Board of Anesthesiology Anesthesiology
- American Board of Internal Medicine Internal Medicine
Clinical Trials
- Efficacy and Safety of Intravenous Acetaminophen Over 48 Hrs for the Treatment of Post-op Pain After Gynecologic Surgery Start of enrollment: 2006 Nov 01
Publications & Presentations
PubMed
- 190 citationsCore outcome domains for chronic pain clinical trials: IMMPACT recommendations.Dennis C Turk, Robert H Dworkin, Robert R Allen, Nicholas Bellamy, Nancy Brandenburg
Pain. 2003-12-01 - 227 citationsDeveloping patient-reported outcome measures for pain clinical trials: IMMPACT recommendationsDennis C. Turk, Robert H. Dworkin, Laurie B. Burke, Richard Gershon, Rothman Ml
Pain. 2006-12-05 - 25 citationsA randomized study of the efficacy and safety of intravenous acetaminophen compared to oral acetaminophen for the treatment of fever.W. Frank Peacock, James B. Breitmeyer, Christine Pan, William B. Smith, Mike A. Royal
Academic Emergency Medicine. 2011-04-01
Press Mentions
- Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study Results for Hospitalized COVID-19 PatientsNovember 9th, 2021
- Sorrento Therapeutics Inc. (NASDAQ: SRNE) Releases Preliminary Phase 2 Abivertinib Study Results for Hospitalized COVID-19 PatientsNovember 9th, 2021
- San Diego Therapeutics Company Battles COVID-19 VariantsMarch 9th, 2021
- Join now to see all
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: